The MyoMobile study will explore the UMANA T1 Heart Monitor, a novel real-time remote cardiac monitoring device. MyoMobile is a prospective, randomized study investigating the effect of a personalized mobile health intervention on the physical activity levels in patients with heart failure
Latest news
Investor
19.12.2024
APSS of Trento granted to Gpi the multichannel access to care service
€52 million contract for software, services, and artificial intelligence.
Investor
20.11.2024
Gpi to meet investors
On November 21 at the CIC Forum 2024, November 27 at the European Midcap, and December 3 at the Mid & Small in Milan
Investor
20.11.2024
Dawn of The Drug Cell
Innovation and technology for a new cell therapy supply chain.
